General MedicationsSOLUTION,CONCENTRATEGeneric
EPINEPHRINE
EPINEPHRINE
Standard Dose
10MG/10ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview EPINEPHRINE is listed in Drugs@FDA under application 218144 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient EPINEPHRINE Form and strength INJECTION;SOLUTION,CONCENTRATE - 10MG/10ML Sponsor GLAND Submission history Latest submission status date: 2025-06-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview EPINEPHRINE is listed in Drugs@FDA under application 218144 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient EPINEPHRINE Form and strength INJECTION;SOLUTION,CONCENTRATE - 10MG/10ML Sponsor GLAND Submission history Latest submission status date: 2025-06-03 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.